October 17, 2019
Stealth Says Experimental Drug Improves Cardiac Function in Barth Syndrome Patients
Read More
October 16, 2019
AI Drug Developer Healx Secures $56 million to Launch Global Rare Disease Accelerator Program
Read More
October 16, 2019
Editas and AskBio Team Up to Develop Novel Treatments for Neurological Diseases
Read More
October 16, 2019
Ipsen Expands Its Rare Disease Portfolio with License for Blueprint Medicines’ FOP Treatment
Read More
October 16, 2019
Alexion Adds to Rare Disease Pipeline with Acquisition of Achillion
Read More
October 16, 2019
FDA Grants ProQR Rare Pediatric Disease Designation for Rare Eye Disease Therapy
Read More
October 15, 2019
With Rights Back in Hand, Reata Reports Positive Results for FA Therapy
Read More
October 14, 2019
Roche Said Study Shows Its Therapy Is Superior to Commonly Used Treatment in Rare Autoimmune Disease
Read More
October 11, 2019
Deep Genomics Boasts an AI First in Drug Discovery
Read More
October 10, 2019
UCB to Acquire Ra Pharmaceuticals in Deal Valued at $2.1 Billion
Read More
October 10, 2019
Reata Pays $330 Million to Reacquire Drug Rights from AbbVie
Read More
October 9, 2019
Bluebird Bio and Novo Nordisk Team Up to Develop Genome Editing Therapies
Read More
Load More
X